Silk Road Medical to Report First Quarter 2022 Financial Results on May 4, 2022
Silk Road Medical, Inc. (NASDAQ: SILK), a company devoted to minimizing stroke risks, will announce its financial results for Q1 2022 on May 4, 2022, post-market. Following this, management will hold a conference call at 1:30 p.m. PT to discuss the results. Investors can join the call by dialing (844) 883-3861 (domestic) or (574) 990-9820 (international) using the conference ID: 4767756. The event will also be available via a live and archived webcast on the company's investor relations page.
- None.
- None.
SUNNYVALE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2022 after market close on Wednesday, May 4, 2022. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by dialing (844) 883-3861 for domestic callers or (574) 990-9820 for international callers, using conference ID: 4767756. A live and archived webcast of the event will be available at https://investors.silkroadmed.com/.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical device company located in Sunnyvale, California, and Plymouth, Minnesota, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. For more information on how Silk Road Medical is delivering brighter patient outcomes through brighter clinical thinking, visit www.silkroadmed.com and connect on Twitter, LinkedIn and Facebook.
Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
investors@silkroadmed.com
FAQ
When will Silk Road Medical report its Q1 2022 financial results?
What time is the conference call for Silk Road Medical's Q1 2022 results?
How can I listen to the Silk Road Medical conference call?